Advertisement
Screener

ENDOLOGIX INC /DE/ Accretion Expense

ENDOLOGIX INC /DE/ Accretion Expense

ENDOLOGIX INC /DE/ reported Accretion Expense of $10.20 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AccretionExpense · last filed 2020-08-10

  • ENDOLOGIX INC /DE/ accretion expense for the quarter ending 2020-06-30 was $5.00M, a 35.60% increase year-over-year.
  • ENDOLOGIX INC /DE/ accretion expense for the quarter ending 2020-03-31 was $5.20M, a 46.37% increase year-over-year.
  • ENDOLOGIX INC /DE/ accretion expense for the quarter ending 2019-09-30 was $3.26M, a 9.56% increase year-over-year.
  • ENDOLOGIX INC /DE/ accretion expense for the quarter ending 2019-06-30 was $3.69M, a 39.16% increase year-over-year.
  • ENDOLOGIX INC /DE/ accretion expense for fiscal 2017 was $10.16M, a 6.56% increase from fiscal 2016.
  • ENDOLOGIX INC /DE/ accretion expense for fiscal 2016 was $9.54M, a 97.01% increase from fiscal 2015.
  • ENDOLOGIX INC /DE/ accretion expense for fiscal 2015 was $4.84M, a 30.20% increase from fiscal 2014.
  • ENDOLOGIX INC /DE/ accretion expense for fiscal 2014 was $3.72M, a 2025.14% increase from fiscal 2013.
Period endAccretion Expense 3 monthAccretion Expense 3 month as first filedAccretion Expense 6 monthAccretion Expense 6 month as first filedAccretion Expense 9 monthAccretion Expense 9 month as first filedAccretion Expense 12 monthAccretion Expense 12 month as first filed
2020-06-30$5.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$10.20M
10-Q · filed 2020-08-10
2020-03-31$5.20M
10-Q · filed 2020-05-27
2019-09-30$3.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$6.94M
derived: sum of 2 quarters · filed 2020-08-10
$10.49M
10-Q · filed 2019-11-07
2019-06-30$3.69M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10
$7.24M
10-Q · filed 2020-08-10
2019-03-31$3.55M
10-Q · filed 2020-05-27
2018-09-30$2.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$5.62M
derived: sum of 2 quarters · filed 2019-11-07
$8.24M
10-Q · filed 2019-11-07
$10.85M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$2.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$5.27M
10-Q · filed 2019-08-09
$7.88M
derived: sum of 3 quarters · filed 2019-08-09
$10.43M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31$2.62M
10-Q · filed 2019-05-08
$5.23M
derived: sum of 2 quarters · filed 2019-05-08
$7.78M
derived: sum of 3 quarters · filed 2019-05-08
$10.24M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$2.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
$5.16M
derived: sum of 2 quarters · filed 2018-11-08
$7.62M
derived: sum of 3 quarters · filed 2018-11-08
$10.16M
10-K · filed 2018-03-13
2017-09-30$2.55M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$5.01M
derived: sum of 2 quarters · filed 2018-11-08
$7.56M
10-Q · filed 2018-11-08
$10.06M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$2.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$5.00M
10-Q · filed 2018-08-09
$7.51M
derived: sum of 3 quarters · filed 2018-08-09
$9.94M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$2.55M
10-Q · filed 2018-05-09
$5.05M
derived: sum of 2 quarters · filed 2018-05-09
$7.48M
derived: sum of 3 quarters · filed 2018-05-09
$9.81M
derived: sum of 4 quarters · filed 2018-05-09
2016-12-31$2.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
$4.94M
derived: sum of 2 quarters · filed 2018-03-13
$7.26M
derived: sum of 3 quarters · filed 2018-03-13
$9.54M
10-K · filed 2018-03-13
2016-09-30$2.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07
$4.76M
derived: sum of 2 quarters · filed 2017-11-07
$7.04M
10-Q · filed 2017-11-07
$8.88M
derived: sum of 4 quarters · filed 2018-03-13
2016-06-30$2.32M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$4.60M
10-Q · filed 2017-08-04
$6.45M
derived: sum of 3 quarters · filed 2018-03-13
$7.46M
derived: sum of 4 quarters · filed 2018-03-13
2016-03-31$2.28M
10-Q · filed 2017-05-05
$4.12M
derived: sum of 2 quarters · filed 2018-03-13
$5.14M
derived: sum of 3 quarters · filed 2018-03-13
$6.14M
derived: sum of 4 quarters · filed 2018-03-13
2015-12-31$1.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13
$2.86M
derived: sum of 2 quarters · filed 2018-03-13
$3.87M
derived: sum of 3 quarters · filed 2018-03-13
$4.84M
10-K · filed 2018-03-13
$4.28M
10-K · filed 2016-02-29
2015-09-30$1.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
$2.02M
derived: sum of 2 quarters · filed 2016-11-08
$3.00M
10-Q · filed 2016-11-08
$2.65M
10-Q · filed 2015-10-30
$4.26M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$1.98M
10-Q · filed 2016-08-05
$1.75M
10-Q · filed 2015-08-05
$3.25M
derived: sum of 3 quarters · filed 2017-03-01
$4.08M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$976.00K
10-Q · filed 2016-05-10
$863.00K
10-Q · filed 2015-04-29
$2.24M
derived: sum of 2 quarters · filed 2017-03-01
$3.07M
derived: sum of 3 quarters · filed 2017-03-01
$3.90M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$1.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$2.10M
derived: sum of 2 quarters · filed 2017-03-01
$2.92M
derived: sum of 3 quarters · filed 2017-03-01
$3.72M
10-K · filed 2017-03-01
$3.31M
10-K · filed 2015-03-02
2014-09-30$831.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30
$1.65M
derived: sum of 2 quarters · filed 2015-10-30
$2.45M
10-Q · filed 2015-10-30
$2.63M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$822.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$1.62M
10-Q · filed 2015-08-05
$1.80M
derived: sum of 3 quarters · filed 2016-02-29
2014-03-31$800.00K
10-Q · filed 2015-04-29
$975.00K
derived: sum of 2 quarters · filed 2016-02-29
2013-12-31$175.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$175.00K
10-K · filed 2016-02-29
2013-09-30$0.00
10-Q · filed 2014-11-04
2012-12-31$0.00
10-K · filed 2015-03-02